Theratechnologies Inc (THTX)
1.21
-0.01
(-0.82%)
USD |
NASDAQ |
Nov 14, 16:00
1.21
0.00 (0.00%)
After-Hours: 20:00
Theratechnologies Net Income (Quarterly): 3.091M for Aug. 31, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| August 31, 2024 | 3.091M |
| May 31, 2024 | 0.987M |
| February 29, 2024 | -4.481M |
| November 30, 2023 | -2.755M |
| August 31, 2023 | -0.746M |
| May 31, 2023 | -10.01M |
| February 28, 2023 | -10.44M |
| November 30, 2022 | -7.929M |
| August 31, 2022 | -7.549M |
| May 31, 2022 | -22.73M |
| February 28, 2022 | -9.032M |
| November 30, 2021 | -9.901M |
| August 31, 2021 | -9.51M |
| May 31, 2021 | -6.392M |
| February 28, 2021 | -5.922M |
| November 30, 2020 | -5.549M |
| August 31, 2020 | -6.768M |
| May 31, 2020 | -5.806M |
| February 29, 2020 | -4.544M |
| November 30, 2019 | -6.455M |
| August 31, 2019 | -1.639M |
| May 31, 2019 | -3.174M |
| February 28, 2019 | -1.228M |
| November 30, 2018 | -0.983M |
| August 31, 2018 | 0.282M |
| Date | Value |
|---|---|
| May 31, 2018 | -1.912M |
| February 28, 2018 | -2.087M |
| November 30, 2017 | -3.061M |
| August 31, 2017 | -2.283M |
| May 31, 2017 | -6.762M |
| February 28, 2017 | -1.700M |
| November 30, 2016 | 0.1241M |
| August 31, 2016 | 0.6783M |
| May 31, 2016 | -0.3818M |
| February 29, 2016 | -0.1129M |
| November 30, 2015 | 0.3571M |
| August 31, 2015 | 0.8904M |
| May 31, 2015 | 0.6582M |
| February 28, 2015 | -0.7305M |
| November 30, 2014 | -2.838M |
| August 31, 2014 | -4.041M |
| May 31, 2014 | 0.928M |
| February 28, 2014 | -3.176M |
| November 30, 2013 | -2.437M |
| August 31, 2013 | -1.836M |
| May 31, 2013 | -1.341M |
| February 28, 2013 | 1.817M |
| November 30, 2012 | -4.367M |
| August 31, 2012 | -0.7029M |
| May 31, 2012 | -1.375M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-22.73M
Minimum
May 2022
3.091M
Maximum
Aug 2024
-6.622M
Average
-6.424M
Median
Net Income (Quarterly) Benchmarks
| Aurinia Pharmaceuticals Inc | 14.35M |
| Edesa Biotech Inc | -1.668M |
| Lexaria Bioscience Corp | -1.782M |
| InMed Pharmaceuticals Inc | -1.938M |
| Xenon Pharmaceuticals Inc | -57.92M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 22.60M |
| Total Expenses (Quarterly) | 16.39M |
| EPS Diluted (Quarterly) | 0.06 |
| Enterprise Value | 74.38M |
| Gross Profit Margin (Quarterly) | 80.00% |
| Profit Margin (Quarterly) | 13.68% |
| Earnings Yield | -4.13% |
| Operating Earnings Yield | 18.14% |
| Normalized Earnings Yield | -1.952 |